A Phase 1, Double-Blind, Placebo-Controlled Trial of Sevasemten (EDG-5506), a Selective Modulator of Fast Skeletal Muscle Contraction, in Healthy Volunteers and Adults With Becker Muscular Dystrophy. [PDF]
Donovan J +11 more
europepmc +1 more source
Label-free proteomic analysis of Duchenne and Becker muscular dystrophy showed decreased sarcomere proteins and increased ubiquitination-related proteins. [PDF]
da Silva JCT +6 more
europepmc +1 more source
Methylphenidate treatment of a Chinese boy with Becker muscular dystrophy combined with attention deficit hyperactivity disorder: a case report. [PDF]
Shen F, Zhou H.
europepmc +1 more source
Patient demographics, clinical characteristics and genetic mutations of DMD and BMD patients in Qatar Epidemiological and genetic profile of Duchenne muscular dystrophy and Becker muscular dystrophy patients in Qatar: a retrospective cohort study. [PDF]
Sawahreh M +4 more
europepmc +1 more source
Editorial: Development of the precision diagnostics and treatment for duchenne/becker muscular dystrophy. [PDF]
Angelini CI.
europepmc +1 more source
The Importance of a PM&R Consultation for Becker Muscular Dystrophy Patients Admitted with Cardiomyopathy. [PDF]
Cherin N, Patel S, Jukic M.
europepmc +1 more source
Diffusion tensor imaging reveals subclinical alterations in muscles of patients with Becker muscular dystrophy. [PDF]
Nava S +6 more
europepmc +1 more source
A novel deep intronic variant introduce dystrophin pseudoexon in Becker muscular dystrophy: A case report. [PDF]
Liu C +12 more
europepmc +1 more source
Cognitive abnormalities in Becker muscular dystrophy: a mysterious link between dystrophin deficiency and executive functions. [PDF]
Pezzoni L +7 more
europepmc +1 more source

